David Bardelang

Dr. David Bardelang


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2023 in JACS Au
Verified
Journal Article
Open access
HYHang Yin
Hang Yin
QCQian Cheng
Qian Cheng
DBDavid Bardelang
David Bardelang
RWRuibing Wang
Ruibing Wang
Cucurbit[n]uril (CB[n]) macrocycles (especially CB[5] to CB[8]) have shown exceptional attributes since their discovery in 2000. Their stability, water solubility, responsiveness to several stimuli, and remarkable binding properties have enabled a growing number of biological applications. Yet, soon after their discovery, the challenge of their functionalization was set. Nevertheless, after more than two decades, a myriad of CB[n] derivatives has been described, many of them used in cells or in vivo for advanced applications. This perspective summarizes key advances of this burgeoning field and points to the next opportunities and remaining challenges to fully express the potential of these fascinating macrocycles in biology and biomedical sciences.

1 January 2021 in Theranostics
Verified
Journal Article
Open access
HYHang Yin
Hang Yin
XZXiangjun Zhang
Xiangjun Zhang
JWJianwen Wei
Jianwen Wei
SLSiyu Lu
Siyu Lu
DBDavid Bardelang
David Bardelang
RWRuibing Wang
Ruibing Wang
Poisons always have fascinated humankind. Initially considered as deleterious or hazardous substances, the modern era has witnessed the controlled utilization of dangerous poisons in medicine and cosmetics. Simultaneously, antidotes have become crucial as reversal agents to counteract the effects of a poison, and they are also used today to positively cancel the benefits of a poison after use. Currently, the majority of poisons are composed of small molecules. This review focuses on recent developments to reverse or prevent toxic effects of poisons by encapsulation in host molecules. Cyclodextrins, cucurbiturils, acyclic cucurbituril derivatives, calixarenes, and pillararenes, have been reported to largely impact the effects of toxic compounds, thus extending the current paradigm of small molecule antidotes by adding a new family of macrocyclic compounds to the current arsenal of antidotes. Along this line of research, endogenous "harmful" species are also sequestered by one or more of these supramolecular host molecules, expanding the potential of supramolecular antidotes to diverse therapeutic areas.

20 August 2020 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
XYXue Yang
Xue Yang
RWRuibing Wang
Ruibing Wang
AKAnthony Kermagoret
Anthony Kermagoret
DBDavid Bardelang
David Bardelang

19 October 2015 in ACS Medicinal Chemistry Letters
Verified
Journal Article
Closed access
Shengke LIShengke LI
Shengke LI
HCHuanxian Chen
Huanxian Chen
XYXue Yang
Xue Yang
DBDavid Bardelang
David Bardelang
Ian WymanIan Wyman
Ian Wyman
RWRuibing Wang
Ruibing Wang

13 January 2025 in Journal of the American Chemical Society
Verified
Journal Article
Open access
MTMian Tang
Mian Tang
ZYZhiqing Yang
Zhiqing Yang
XTXingchen Tang
Xingchen Tang
HMHe Ma
He Ma
BXBeibei Xie
Beibei Xie
RWRuibing Wang
Ruibing Wang
Despite the development of various controlled release systems for antitumor therapies, off-target side effects remain a persistent challenge. In situ therapeutic synthesis from biocompatible substances offers a safer and more precise alternative. This study presents a hypoxia-initiated supramolecular free radical system capable of inducing intracellular polymerization, thereby disrupting the cytoskeleton and organelles within 4T1 cells. The system utilizes a 2:1 supramolecular host-guest complex of cucurbit[7]uril (CB[7]) and perylene diimide derivative (PDI), termed PDI+2CB[7], which is selectively reduced by the tumor's hypoxic and reducing environment to generate delocalized free radical anions. CB[7] effectively stabilizes these anions, enabling the PDI+2CB[7] complex to initiate free radical polymerization with 2-hydroxyethyl methacrylate (HEMA) inside the 4T1 cells. The resulting in situ polymerization significantly disrupts tumor metabolism, leading to a strong antitumor response without systemic toxicity. This study demonstrates that stable, endogenous stimulus-induced supramolecular free radicals can trigger intracellular polymerization reactions, achieving a selective and effective antitumor therapy without conventional chemotherapeutic agents.

11 May 2018 in Organic Letters
Verified
Journal Article
Closed access
HYHang Yin
Hang Yin
RRRoselyne Rosas
Roselyne Rosas
DGDidier Gigmes
Didier Gigmes
OOOlivier Ouari
Olivier Ouari
RWRuibing Wang
Ruibing Wang
DBDavid Bardelang
David Bardelang